Vincent Fallet
137 works · 2,671 citations · h-index 23
Top works
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
- Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages
- High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets
- Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung
- Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer
- Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer
- Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
- RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion
- Lung cancer is also a hereditary disease
- MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung
- European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer
- Exposure–Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
- Dramatic Radiation Recall Pneumonitis Induced by Osimertinib after Palliative Thoracic Radiotherapy for Lung Cancer
- Prospective screening for ALK: Clinical features and outcome according to ALK status
- c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas
- Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC
- Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort
- Secondary Resistance to Erlotinib: Acquired T790M Mutation and Small-Cell Lung Cancer Transformation in the Same Patient
- Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer